Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc Analysis.

Saved in:
Bibliographic Details
Title: Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY 94-9027 for Severe Haemophilia A: A Post Hoc Analysis.
Authors: Lalezari S; National Hemophilia Center, Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Acquadro M; Patient-Centered Outcomes, ICON plc, Lyon, France., de Bock E; Patient-Centered Outcomes, ICON plc, Lyon, France., Lambert J; Patient-Centered Outcomes, ICON plc, Lyon, France., Simpson ML; Rush Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, IL, USA. mindy_l_simpson@rush.edu.
Source: Advances in therapy [Adv Ther] 2020 Jun; Vol. 37 (6), pp. 2763-2776. Date of Electronic Publication: 2020 May 14.
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1865-8652
DOI:10.1007/s12325-020-01374-2